669002-79-3

Upstream product

• 669002-19-1 (4-pyrrolidin-1-ylmethyl-phenyl)-acetonitrile 
• 64-17-5 ethanol 
• 123-75-1 pyrrolidine 
• 43153-12-4 ethyl 2-(4-formylphenyl)acetate 

Downstream Products

• 669002-80-6 2-methyl-1-(4-pyrrolidin-1-ylmethyl-phenyl)-propan-2-ol 
• 1241746-10-0 [4-(1-pyrrolidinylmethyl)phenyl]acetic acid, hydrochloride 

Relevant academic research and scientific papers

QU1NOLINE DERIVATIVES AND THEIR USES FOR RHINITIS AND URTICARIA

The present invention relates to compounds of formula (I) and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various diseases, such as allergic rhinitis.

New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture

The present invention relates to carboxamide compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1, R2, R3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.